SCHEMBL949225

SCHEMBL949225

[CH2]C(c1ccccc1)N1CCCCC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.63
CYP2C19 P33261 6/20 0.63
CYP2D6 P10635 6/20 0.63
KCNA5 P22460 6/20 0.63
CYP3A4 P08684 5/20 0.63
CYP2C9 P11712 5/20 0.63
KCNH2 Q12809 4/20 0.63
KCNE1 P15382 2/20 0.63
TSHR P16473 2/20 0.52
GAA P10253 1/20 0.52
LMNA P02545 2/20 0.48
HPGD P15428 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK1 P28482 1/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAOB P27338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL945419 0.98 CYP2D6 (0.61) CYP1A2CYP2C19CYP2D6KCNA5CYP3A4
SCHEMBL17240261 0.84 CYP1A2 (0.46) CYP1A2CYP2C19CYP2D6KCNA5CYP3A4
SCHEMBL9534090 0.79 CYP2D6 (0.43) CYP1A2CYP2C19CYP2D6KCNA5CYP3A4
SCHEMBL5000351 0.79 KCNA5 (0.53) CYP2C19CYP2D6KCNA5CYP3A4CYP2C9
SCHEMBL8671188 0.79 CYP2D6 (0.66) CYP2C19CYP2D6CYP3A4KCNH2TSHR
SCHEMBL2430209 0.79 MEN1 (0.66) CYP1A2CYP2C19CYP2D6CYP2C9KMT2A
SCHEMBL855649 0.79 KCNA5 (0.53) CYP2C19CYP2D6KCNA5CYP3A4CYP2C9
SCHEMBL8670698 0.79 L3MBTL3 (0.51) GAALMNAALDH1A1KDM4EL3MBTL3
SCHEMBL17240219 0.77 SLC6A2 (0.47) CYP1A2CYP2C19CYP2D6KCNA5CYP3A4
SCHEMBL16227210 0.77 KCNA5 (1.00) CYP1A2CYP2C19CYP2D6KCNA5CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014170343-A1 DEPOLARIZING AGENTS AND NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS FOR TREATING DOPAMINERGIC-RELATED DISORDERS ICM (INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE) (FR) 2014-10-23 WO disclosed
CN-1976922-B 4-amino-5-cyanopyrimidine derivatives OTSUKA PHARMA CO LTD 2012-09-05 CN disclosed
US-7989446-B2 4-amino 5-cyanopyrimidine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2011-08-02 US disclosed
US-20110009620-A1 4-Amino-5-cyanopyrimidine derivatives OTSUKA PHARMACEUTICAL CO., LTD. 2011-01-13 US disclosed
US-7834002-B2 4-amino-5-cyanopyrimidine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-11-16 US disclosed
US-20080182854-A1 4-Amino-5-Cyanopyrimidine Derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-07-31 US disclosed
EP-1740574-B1 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES OTSUKA PHARMA CO LTD (JP) 2007-06-27 EP disclosed
CN-1976922-A 4-amino-5-cyanopyrimidine derivatives OTSUKA PHARMA CO LTD (JP) 2007-06-06 CN disclosed
EP-1740574-A2 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES Otsuka Pharmaceutical Company, Limited (JP) 2007-01-10 EP disclosed
WO-2005105778-A2 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-11-10 WO disclosed
US-4128553-A HERBICIDE THE DOW CHEMICAL COMPANY (US) 1978-12-05 US disclosed
US-4128551-A HERBICIDE THE DOW CHEMICAL CO. (US) 1978-12-05 US disclosed
US-4098792-A HERBICIDES THE DOW CHEMICAL COMPANY (US) 1978-07-04 US disclosed
US-4085279-A HERBICIDES THE DOW CHEMICAL COMPANY (US) 1978-04-18 US disclosed
US-4085278-A HERBICIDES THE DOW CHEMICAL COMPANY (US) 1978-04-18 US disclosed
US-4082758-A HERBICIDES THE DOW CHEMICAL COMPANY (US) 1978-04-04 US disclosed
US-4082759-A HERBICIDES THE DOW CHEMICAL COMPANY (US) 1978-04-04 US disclosed
US-4058533-A HERBICIDES THE DOW CHEMICAL COMPANY (US) 1977-11-15 US disclosed
US-4014888-A HERBICIDES THE DOW CHEMICAL COMPANY (US) 1977-03-29 US disclosed
US-3989507-A HERBICIDES THE DOW CHEMICAL COMPANY (US) 1976-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009620-A1 4-Amino-5-cyanopyrimidine derivatives ADORA2A, ADORA1, ADORA3 CYP1A2 497/4885CYP2C19 609/4885CYP2D6 1784/4885
US-20080182854-A1 4-Amino-5-Cyanopyrimidine Derivatives ADORA2A, ADORA1, ADORA3 CYP1A2 497/4885CYP2C19 609/4885CYP2D6 1784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.